These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16632035)

  • 1. Should we reconsider the advanced glycation end product issue in hemodialysis patients?
    Schwedler SB; Wanner C
    Am J Kidney Dis; 2006 May; 47(5):923; author reply 923-4. PubMed ID: 16632035
    [No Abstract]   [Full Text] [Related]  

  • 2. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
    Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
    Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for accumulation of advanced glycation end products in acute renal failure.
    Sebeková K; Heidland A; Waidheim A; Schinzel R
    Nephron; 2000 Oct; 86(2):186-7. PubMed ID: 11014991
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycation end products and mortality in hemodialysis patients.
    Schwedler SB; Metzger T; Schinzel R; Wanner C
    Kidney Int; 2002 Jul; 62(1):301-10. PubMed ID: 12081592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients.
    Busch M; Schwenzky A; Franke S; Stein G; Wolf G
    Blood Purif; 2012; 34(1):3-9. PubMed ID: 22699860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
    Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
    Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
    Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
    Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients.
    Taki K; Takayama F; Tsuruta Y; Niwa T
    Kidney Int; 2006 Jul; 70(1):218-24. PubMed ID: 16723988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
    Aubert CE; Michel PL; Gillery P; Jaisson S; Fonfrede M; Morel F; Hartemann A; Bourron O
    Diabetes Metab Res Rev; 2014 Nov; 30(8):679-85. PubMed ID: 24449227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
    Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
    J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
    Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
    J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin T and advanced glycation end-products in hemodialysis patients.
    Taki K; Tsuruta Y; Niwa T
    Am J Nephrol; 2008; 28(5):701-6. PubMed ID: 18431051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
    Honda H; Hosaka N; Aoshima Y; Hirai Y; Michihata T; Akizawa T
    Clin Exp Hypertens; 2012; 34(1):17-23. PubMed ID: 22149003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study.
    Baragetti I; Furiani S; Vettoretti S; Raselli S; Maggi FM; Galli F; Catapano AL; Buccianti G
    Blood Purif; 2006; 24(4):369-76. PubMed ID: 16755158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.